Valuation: Provexis plc

Market Cap 25.22M 33.79M 29.53M 27.3M 47.49M 3.25B 48.35M 326M 128M 1.59B 127M 124M 5.47B P/E 2024
-20.9x
P/E 2025 -22.6x
Enterprise Value 24.51M 32.84M 28.7M 26.53M 46.16M 3.15B 46.99M 316M 124M 1.54B 123M 121M 5.32B EV / Sales 2024
17x
EV / Sales 2025 7.62x
Free-Float
79.16%
Yield 2024 *
-
Yield 2025 -
1 day-9.63%
1 week+1.24%
Current month-4.31%
1 month+29.79%
3 months+19.61%
6 months+28.42%
Current year+35.56%
1 week 1.14
Extreme 1.14
1.35
1 month 0.8
Extreme 0.803
1.35
Current year 0.77
Extreme 0.77
1.55
1 year 0.55
Extreme 0.55
1.55
3 years 0.4
Extreme 0.4
1.55
5 years 0.4
Extreme 0.4
1.55
10 years 0.2
Extreme 0.2
1.55
Manager TitleAgeSince
Chief Executive Officer - -
Chief Tech/Sci/R&D Officer 52 1999-12-31
Director TitleAgeSince
Director/Board Member - 2010-11-10
Chairman 79 2005-05-31
Director/Board Member 52 2019-04-11
Date Insider Type Main position Quantity % Market Cap.
25-01-06Free

Chief Executive Officer

30,000,000 1.2788%
23-01-23Free

Chief Technology Officer

17,000,000 0.7665%
23-01-23Free

Chief Executive Officer

17,000,000 0.7665%
Change 5-day change 1-year change 3-year change Capi.($)
-9.63%+1.24%+57.42%+95.20% 42.37M
+2.38%-2.57%+32.29%+81.02% 12.74B
-0.43%+9.46%-27.16%+226.31% 7.71B
+1.52%+3.08%-19.76%-54.69% 2.28B
+5.71%+8.86% - - 1.49B
-5.10%-13.20%-79.40%-66.72% 1.48B
-6.56%-6.85%+26.06%-7.62% 1.36B
+3.44%+3.97%-27.72%-23.46% 1.25B
-0.22%+1.31%+19.02%+45.08% 1.23B
-7.21%-6.23%-63.73%-66.43% 1.18B
Average -1.61%+0.28%-9.22%+25.41% 3.08B
Weighted average by Cap. +0.57%+2.16%-0.33%+85.23%

Financials

2024 2025
Net sales 802K 1.07M 939K 868K 1.51M 103M 1.54M 10.35M 4.06M 50.54M 4.04M 3.95M 174M 1.29M 1.73M 1.51M 1.4M 2.43M 166M 2.48M 16.68M 6.54M 81.43M 6.5M 6.36M 280M
Net income -586K -785K -686K -635K -1.1M -75.45M -1.12M -7.57M -2.97M -36.94M -2.95M -2.89M -127M -453K -607K -530K -490K -853K -58.26M -868K -5.84M -2.29M -28.53M -2.28M -2.23M -98.23M
Net Debt -189K -254K -222K -205K -357K -24.37M -363K -2.44M -959K -11.93M -953K -932K -41.09M -708K -949K -829K -766K -1.33M -91.13M -1.36M -9.14M -3.59M -44.62M -3.56M -3.48M -154M
Logo Provexis plc
Provexis plc is a United Kingdom-based company that develops, licenses and sells the proprietary, scientifically proven Fruitflow heart-health functional food ingredient. Fruitflow is a natural extract from tomatoes which has been shown in human trials to reduce the propensity for aberrant blood clotting, typically associated with cardiovascular disease, which can lead to heart attack and stroke. The extract is available as a spray-dried powder, and it can be included in a broad range of food, beverage and dietary supplement formats. Fruittflow is a highly concentrated form of bioactives which is lycopene-free and contains over 30 known antiplatelet compounds. The Company also offers Fruitflow+, Omega-3, and dietary supplement products which are sold directly to consumers. In addition, the Company supplies Fruitflow as an ingredient to brand owners in the food, beverage, and supplement sectors through DSM Nutritional Products’ distribution network.
Employees
2
Date Price Change Volume
26-07-14 GBX 1.220 -9.63% 145,166
26-07-13 GBX 1.350 +8.43% 1,303,087
26-07-10 GBX 1.245 +2.05% 2,043,759
26-07-09 GBX 1.220 -2.01% 127,280
26-07-08 GBX 1.245 +3.32% 212,568